Resultado da Busca
David Earl Nichols (born December 23, 1944, Covington, Kentucky) is an American pharmacologist and medicinal chemist. Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs since 1969.
2017. Effects of Schedule I drug laws on neuroscience research and treatment innovation. DJ Nutt, LA King, DE Nichols. Nature Reviews Neuroscience 14 (8), 577-585. , 2013. 392. 2013. Effects of enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices.
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction.
12 de jan. de 2024 · Dr. David E. Nichols is one of the world’s leading experts in the field of psychedelic pharmacology. He’s a Professor Emeritus of Pharmacology at Purdue University and the co-founder of the Heffter Research Institute.
- 1944-Present
- Pharmacology Professor
- American
1 de abr. de 2018 · This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline.
David E Nichols 1. Affiliation. 1 Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA. drdave@purdue.edu. PMID: 32398764. DOI: 10.1038/s41429-020-0311-8. Abstract. Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is an indole-based secondary metabolite produced by numerous species of mushrooms.
david e. nichols, phd VICE-PRESIDENT, FOUNDER Dr. Nichols, PhD originally conceived of a privately funded Institute as the most effective mechanism for bringing research on psychedelic agents into the modern era of neuroscience.
